Samphire Neuroscience Revenue and Competitors
Employee Data
- Samphire Neuroscience has 12 Employees.
- Samphire Neuroscience grew their employee count by 9% last year.
Samphire Neuroscience's People
Name | Title | Email/Phone |
---|
Samphire Neuroscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 45 | 55% | N/A | N/A |
#2 | N/A | 10 | 25% | N/A | N/A |
#3 | $75M | 1730 | N/A | N/A | N/A |
#4 | N/A | 5 | 150% | N/A | N/A |
#5 | N/A | 2 | 0% | N/A | N/A |
#6 | N/A | 41 | 5% | N/A | N/A |
#7 | N/A | 37 | 85% | N/A | N/A |
#8 | N/A | 8 | 60% | N/A | N/A |
#9 | N/A | 373 | -1% | N/A | N/A |
#10 | N/A | 17 | 42% | N/A | N/A |
What Is Samphire Neuroscience?
At Samphire Neuroscience, we're on a mission to transform women's health through brain based innovation. Our vision is simple: to create a world where women have access to medical grade solutions that empower them to take control of their health—without compromising on technology, design, or lifestyle.\n\nBuilding on over 30 years of research and clinical expertise, we’ve developed Nettle, the world's first brain stimulating headband for the at-home alleviation of PMS and period pain symptoms. Available to buy in the UK and across the EU, Nettle is also undergoing clinical trials in PMDD and endometriosis populations.\n\nSamphire Neuroscience also offers neuroscience-backed cycle tracking via the Samphire app, available on the Apple App Store and Google Play.\n\nBut we’re just getting started. We're actively developing other neurotechnology to address the unique health needs of women everywhere - and we can't wait to share what's coming next.
keywords:N/AN/A
Total Funding
12
Number of Employees
N/A
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $1.6M | 12 | 20% | N/A |
#3 | $2.2M | 12 | -37% | N/A |
#4 | $1M | 12 | N/A | N/A |
#5 | $1M | 12 | N/A | N/A |